Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
SARS CORP.Listing unverified | OtherD (derivative) | $80K | SEC | ||
SARS CORP.Listing unverified | Other | $32K | SEC | ||
SARS CORP.Listing unverified | Buy | $4.8K | conv 33Cluster | SEC | |
SARS CORP.Listing unverified | Sell | $10.5K | SEC | ||
SARS CORP.Listing unverified | Sell | $23.4K | SEC | ||
SARS CORP.Listing unverified | Buy | $112.5K | conv 68Unusual size | SEC | |
SARS CORP.Listing unverified | Buy | $560 | conv 16 | SEC | |
SARS CORP.Listing unverified | Buy | $140 | conv 16 | SEC | |
SARS CORP.Listing unverified | Buy | $195 | conv 17 | SEC | |
SARS CORP.Listing unverified | Buy | $520 | conv 16 | SEC | |
SARS CORP.Listing unverified | Buy | $550 | conv 16 | SEC | |
SARS CORP.Listing unverified | Buy | $550 | conv 16 | SEC | |
SARS CORP.Listing unverified | Buy | $390 | conv 32Unusual sizeFirst in 12mo | SEC | |
SARS CORP.Listing unverified | Buy | $300 | conv 16 | SEC | |
SARS CORP.Listing unverified | Buy | $3.8K | conv 35First in 12mo | SEC | |
SARS CORP.Listing unverified | Buy | $4K | conv 35First in 12mo | SEC | |
SARS CORP.Listing unverified | Buy | $2.6K | conv 35First in 12mo | SEC |